Kazakhstan’s government has approved major investment projects to build four modern pharmaceutical manufacturing plants to expand domestic drug production.
The total investment is estimated at 173 billion tenge (about $340 million). The projects will be implemented by four companies: AltINFARM LLP; Nobel Almaty Pharmaceutical Factory JSC; Abdi Ibrahim Global Pharm LLP; and MSP-Romfarm LLP.
International partnerships
Several of the projects involve international partners. AltINFARM is working with China’s Sinopharm, Sinovac, and Kangtai Biological Technology. Abdi Ibrahim Global Pharm’s partner is Nobel İlaç of Turkey, while MSP-Romfarm is partnering with World Medicine of Turkey and Rompharm of...